Futura Medical PLC FUM.L

GBX1.13 GBX0.02 (1.32%) 1D

Last Updated: Mar 27, 12:00 AM·LSE

FUM.L Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: January 23, 2026

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Futura Medical PLC (FUM.L)

Based on 9 analysts giving stock ratings to Futura Medical PLC in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
45
Buy
44
Hold
11
Sell
0
Strong Sell
0
Futura Medical PLC

Futura Medical PLC. Stock Analysis FUM.L

United Kingdom Health Care Nano Cap Report:
Futura Medical Plc engages in the development of pharmaceutical and healthcare products. The company is headquartered in Guildford, Surrey. The company went IPO on 2006-07-10. The firm is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The firm has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.
Read More

Futura Medical PLC (FUM.L) Chart

Key Statistics of Futura Medical PLC (FUM.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX1.10GBX1.14

Today's Open

GBX1.14

Volume

1.47M

P/E Ratio (TTM)

5.72

52 Week Range

GBX1.00GBX15.00

Market Cap

767.35M

Avg. Volume

622.53K

Dividend Yield

-

Financial Metrics & Statements of Futura Medical PLC (FUM.L)

Community-Curated Collections with Futura Medical PLC (FUM.L) ( With FUM.L )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Futura Medical PLC (FUM.L)

  • According to Musaffa’s Shariah screening methodology, Futura Medical PLC (FUM.L) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.